Skip Nav Destination
Advances in Brief
Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support.
A D Elias; C Wheeler; L J Ayash; G Schwartz; J Ibrahim; L Mills; M McCauley; N Coleman; D Warren; L Schnipper; K H Antman; B A Teicher; E Frei, 3rd
Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen.
E Warner; D Hedley; I Andrulis; R Myers; M Trudeau; D Warr; K I Pritchard; M Blackstein; P E Goss; E Franssen; K Roche; S Knight; S Webster; R A Fraser; S Oldfield; W Hill; R Kates
Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum.
N Boku; K Chin; K Hosokawa; A Ohtsu; H Tajiri; S Yoshida; T Yamao; H Kondo; K Shirao; Y Shimada; D Saito; T Hasebe; K Mukai; S Seki; H Saito; P G Johnston
p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer.
W P Bennett; W S el-Deiry; W L Rush; D G Guinee, Jr; A N Freedman; N E Caporaso; J A Welsh; R T Jones; A Borkowski; W D Travis; M V Fleming; V Trastek; P C Pairolero; H D Tazelaar; D Midthun; J R Jett; L A Liotta; C C Harris